Dr. Douglas P. Clark
Director,
immunology
Biomarker Ltd
Chad
Biography
Dr. Douglas P. Clark is Director, Scientific Founder, and Former Acting CEO and Former CMO of BioMarker Strategies. He was recently named Chairman of the Pathology Department of the University of New Mexico Health Sciences Center. From 2011-2013, he served as CMO and Acting CEO of BioMarker Strategies and as an adjunct Professor of Pathology and Oncology at The Johns Hopkins Medical Institutions, where he served as the director of the Division of Cytopathology from 2002-2010. He is a board-certified anatomic pathologist and cytopathologist with experience in oncology, microbiology and molecular diagnostics. He serves on the editorial boards of Cancer Cytopathology and Expert Review of Molecular Diagnostics.
Research Interest
Dr. Clark has been at the forefront of efforts to integrate molecular biomarkers into the field of pathology. At the University of New Mexico, he will spearhead efforts to expand translational and personalized medicine initiatives. At Johns Hopkins, he successfully developed a comprehensive molecular cytopathology program that serves as a vital resource to clinical trial development, particularly in the area of oncology. This work has led to numerous publications and a pending patent for a targeted therapy-related diagnostic test that has been licensed by BioMarker Strategies. Dr. Clark received his M.D. degree from The Johns Hopkins School of Medicine and his B.A. degree in biochemistry and molecular biology from Northwestern University.
